 |
Top 13 Nanomedicine startups
Oct 10, 2024 | By Jason Kwon | 24 |
These startups develop and use nanoparticles, biological nanomachines and nanomaterials to diagnose and treat diseases.
1
Country: USA | Funding: $316.6M
T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts utilizing T2MR target sepsis, hemostasis and Lyme disease, which are areas of significant unmet medical need in which existing therapies could be more effective with improved diagnostics.
T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts utilizing T2MR target sepsis, hemostasis and Lyme disease, which are areas of significant unmet medical need in which existing therapies could be more effective with improved diagnostics.
2
Country: USA | Funding: $135.5M
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
3
Country: Japan | Funding: ¥8.3B
We challenge to integrate and develop nano and bio technologies. Our mission is to contribute to people's health and well-being with better process and quality.
We challenge to integrate and develop nano and bio technologies. Our mission is to contribute to people's health and well-being with better process and quality.
4
Country: German | Funding: $20M
TaxolCur develops new approach to treat cancer using to HYBRID-NANOENGINEERING attack on tumor stem cells and microenvironment in one formulation.
TaxolCur develops new approach to treat cancer using to HYBRID-NANOENGINEERING attack on tumor stem cells and microenvironment in one formulation.
5
Country: USA | Funding: $13.5M
Zylö Therapeutics has an innovative sustained-release drug-delivery system that uses patented hydrogel-derived nanoparticles
Zylö Therapeutics has an innovative sustained-release drug-delivery system that uses patented hydrogel-derived nanoparticles
6
Country: USA
At Keystone Nano, we tackle huge challenges at the nano level. We’re developing nanoscale solutions for better treatment of cancer and for improvements in difficult-to-solve industrial chemistries. We have both an internal development program and a series of co-development programs with partner companies, using our unique nanoparticles to deliver their actives.
At Keystone Nano, we tackle huge challenges at the nano level. We’re developing nanoscale solutions for better treatment of cancer and for improvements in difficult-to-solve industrial chemistries. We have both an internal development program and a series of co-development programs with partner companies, using our unique nanoparticles to deliver their actives.
7
Country: USA | Funding: $2.4M
Nanomedical Diagnostics is the first company to combine expertise in biology, nanotechnology, surface chemistry, engineering, and manufacturing to create practical and scaleable graphene biological field effect transistor (BioFET) products. Our ongoing mission is applying our cutting-edge capabilities to produce affordable diagnostic and monitoring platforms that deliver accurate, timely health information and improve patient outcomes and lives.
Nanomedical Diagnostics is the first company to combine expertise in biology, nanotechnology, surface chemistry, engineering, and manufacturing to create practical and scaleable graphene biological field effect transistor (BioFET) products. Our ongoing mission is applying our cutting-edge capabilities to produce affordable diagnostic and monitoring platforms that deliver accurate, timely health information and improve patient outcomes and lives.
8
Country: Canada | Funding: $5.5M
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues.
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues.
9
Country: Australia | Funding: $5.1M
iCeutica has developed the Encapsulated Organic Nanoparticles (EON™) Platform to produce consistent nano-sized drug particles.
iCeutica has developed the Encapsulated Organic Nanoparticles (EON™) Platform to produce consistent nano-sized drug particles.
10
Country: USA
NuVascular Technologies, Inc. is developing the next-generation of medical devices that will specifically treat patients suffering from end-stage renal (kidney) disease with the goal of helping patients live better and longer lives.
NuVascular Technologies, Inc. is developing the next-generation of medical devices that will specifically treat patients suffering from end-stage renal (kidney) disease with the goal of helping patients live better and longer lives.
